| Value | ₹166.1 Cr |
|---|
BSE filing, NSE: HOCL. Summary written from the filing by ALFA Finder's alert engine.
Hindustan Organic Chemicals Ltd: key numbers
- Share price
- ₹49.61
- Market cap
- ₹333.2 Cr
- Revenue (annual)
- ₹573.8 Cr
- Net profit (annual)
- ₹-12.73 Cr
- P/E (TTM)
- -129.1×Sector 34.1×
- Promoter holding
- 58.78%+0.00% QoQ
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Organic Chemicals Ltd
All →Hindustan Organic Chemicals Board Meeting Date
HOCL intimates its 429th Board Meeting scheduled for 4 Nov 2026 to consider Q2 FY27 unaudited results and routine agenda. Trading window remains closed from 1 Oct 2026 until 48 hours post-announcement.
Hindustan Organic Chemicals Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Hindustan Organic Chemicals Price Movement Clarification
Hindustan Organic Chemicals Ltd clarified to BSE that recent price movements may be linked to consecutive quarterly profits. The company is unaware of any other material developments.
Hindustan Organic Chemicals Annual General Meeting
Hindustan Organic Chemicals Ltd held its 65th Annual General Meeting on September 25, 2026, through video conferencing to transact ordinary and special business.
Hindustan Organic Chemicals Other Announcement
HOCL disclosed CAG's re-appointment of M/s. Balan & Co as statutory auditor for FY 2026-27. This is a routine compliance filing for a government company.
Hindustan Organic Chemicals Annual General Meeting
Hindustan Organic Chemicals Ltd has issued the notice for its 65th Annual General Meeting, scheduled to be held on September 25, 2026, via video conferencing.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr